Digital Quantification of Tumor Cellularity as a Novel Prognostic Feature of Non–Small Cell Lung Carcinoma
Modern Pathology · 2023
DOI: 10.1016/j.modpat.2022.100055 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Pathology, 2023. Verfasst von Sherman Lin und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, University of Western Ontario, London, Ontario, Canada. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Adenocarcinoma, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Western University.
Abstract (Originalsprache)
Non-small cell lung carcinoma is currently staged based on the size and involvement of other structures. Tumor size may be a surrogate measure of the total number of tumor cells. A recently revised reporting system for adenocarcinoma incorporates high-risk histologic patterns, which may have increased cellular density. Modern digital image analysis tools can be utilized to automate the quantification of cells. In this study, we tested the hypothesis that tumor cellularity can be used as a novel prognostic tool for lung cancer. Digital slides from The Cancer Genome Atlas lung adenocarcinoma (ADC) data set (n = 213) and lung squamous cell carcinoma (SCC) data set (n = 90) were obtained and analyzed using QuPath. The number of tumor cells was normalized with the surface area of the tumor to provide a measure of tumor cell density. Tumor cellularity was calculated by multiplying the size of the tumor with the cell density. Major histologic patterns and grade were compared with the tumor density of the lung ADC and lung SCC cases. The overall and progression-free survival were compared between groups of high and low tumor cellularity. High-grade histologic patterns in the ADC and SCC cases were associated with greater tumor densities compared with low-grade patterns. Cases with lower tumor cellularity had improved overall and progression-free survival compared with cases with higher cellularity. These results support tumor cellularity as a novel prognostic tool for non-small cell lung carcinoma that considers tumor stage and grade elements.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, University of Western Ontario, London, Ontario, Canada.
- Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.
- Department of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada.
- Department of Pathology, Hospital Universitari Vall d'Hebron, Barcelona, Catalunya, Spain.
- Department of Pathology and Laboratory Medicine, University of Western Ontario, London, Ontario, Canada. Electronic address: matthew.cecchini@lhsc.on.ca.
Förderung
- Western University
Zitieren
APA
Lin, S., Samsoondar, J. P., Bandari, E., Keow, S., Bikash, B., Tan, D., Martinez-Acevedo, J., Loggie, J., Pham, M., Wu, N. J., Misra, T., Lam, V. H. K., Sansano, I., & Cecchini, M. J. (2023). Digital Quantification of Tumor Cellularity as a Novel Prognostic Feature of Non–Small Cell Lung Carcinoma. Modern Pathology. https://doi.org/10.1016/j.modpat.2022.100055
Vancouver
Lin S, Samsoondar JP, Bandari E, Keow S, Bikash B, Tan D, et al. Digital Quantification of Tumor Cellularity as a Novel Prognostic Feature of Non–Small Cell Lung Carcinoma. Modern Pathology. 2023. doi:10.1016/j.modpat.2022.100055
BibTeX
@article{Lin2023,
author = {Lin, Sherman and Samsoondar, Joshua P and Bandari, Ela and Keow, Samantha and Bikash, Binit and Tan, Djarren and Martinez-Acevedo, Jacobo and Loggie, John and Pham, Michelle and Wu, Nina J and Misra, Tanya and Lam, Victor H K and Sansano, Irene and Cecchini, Matthew J},
title = {Digital Quantification of Tumor Cellularity as a Novel Prognostic Feature of Non–Small Cell Lung Carcinoma},
journal = {Modern Pathology},
year = {2023},
doi = {10.1016/j.modpat.2022.100055}
}
EUVIMED